Keyword: DCAT

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...

Chemistry & Life Sciences

Challenges Facing Pharmaceutical Manufacturing

23.11.2020 -

Sean Diver, president of DCAT speaks about the pharmaceutical industry’s role during the Covid-19 pandemic, trends in drug manufacturing, and key issues for the EU...


Sean Diver Elected DCAT President

06.11.2020 -

On November 1, 2020, Sean Diver took the reins as President of the Drug, Chemical & Associated Technologies Association (DCAT).

Strategy & Management

Expansions in High-Potency API Manufacturing

14.09.2020 -

DCAT Value Chain Insights rounds up recent expansion activity for highly potent drug substances and drug products.

Markets & Companies

High-level Meetings, Networking, and Education

23.12.2019 - DCAT Week, held again on March 23-26, 2020, in New York City, is a premier business development event for companies engaged in pharmaceutical development and manufacturing...

Markets & Companies

CDMO Market Forces Re-shape of M&A Activity

19.08.2019 - Mergers and acquisitions (M&A) have played a pivotal role in the evolution of the contract development and manufacturing (CDMO) industry. However, after an especially active year...

Chemistry & Life Sciences

DCAT Week 2019

10.01.2019 - Each year in March, the pharmaceutical manufacturing industry gathers in New York City for DCAT Week, and this year is no exception. DCAT Week ’19, the flagship event of the Drug...


DCAT Announces New Board of Directors

02.11.2018 - Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...